Ophthalmic genetics explores the intricate interplay between genetic elements and eye-related ailments, spanning from congenital anomalies like retinoblastoma to age-related macular degeneration. This field is pivotal for diagnosis, prognosis, and the formulation of targeted therapies. Advancements in genomic technologies have revolutionized ophthalmic genetics, facilitating precise genetic testing and personalized treatments. Through genetic screening, clinicians can pinpoint individuals at risk, provide tailored interventions, and offer genetic counseling to affected families. Furthermore, ophthalmic genetics contributes significantly to understanding the complex inheritance patterns of ocular disorders, illuminating genotype-phenotype correlations and aiding in the identification of new therapeutic avenues. By dissecting the genetic foundations of eye diseases, researchers strive to advance treatments and enhance patient care outcomes.







Title : Why a paediatric orthoptic oncology service matters
Shenika Tailor, University Hospitals of Leicester NHS Trust, United Kingdom
Title : Stereotactic radiotherapy for wet age-related macular degeneration: year 4 results of a randomised, double-masked, sham-controlled trial
Tim Jackson, King’s College London, United Kingdom